BridgeBio Pharma, Inc. SEC filings BBIO

BridgeBio Pharma, Inc. has 833 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

BridgeBio Pharma, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Other events
Oct 13, 2026 Oct 6, 2026
8-K Current report
Other events
Aug 31, 2026 Aug 31, 2026
8-K Current report
Material agreement, Other events
Aug 17, 2026 Aug 13, 2026
424B7 Filing Aug 14, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
S-3ASR Automatic shelf registration Jul 24, 2026 —
S-8 Employee stock plan registration Jul 24, 2026 —
8-K Current report
Other events
Jul 22, 2026 Jul 22, 2026
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jul 2, 2026 Jul 1, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 26, 2026 Jun 22, 2026
8-K Current report
Other events
May 27, 2026 May 27, 2026
8-K Current report
Other events
May 13, 2026 May 12, 2026
8-K Current report
Material agreement, Agreement ended
May 8, 2026 May 7, 2026
S-3ASR Automatic shelf registration May 8, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Other events
May 7, 2026 May 6, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 22, 2026
8-K Current report
Other events
Mar 30, 2026 Mar 30, 2026
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
8-K Current report
Other events
Feb 12, 2026 Feb 12, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jan 21, 2026 Jan 14, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 12, 2026 Jan 12, 2026
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Oct 27, 2025 Oct 27, 2025
S-8 Employee stock plan registration Aug 5, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Material agreement, New debt
Jul 2, 2025 Jun 27, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jun 23, 2025 Jun 20, 2025
DEFA14A Additional proxy material May 9, 2025 —
DEFA14A Additional proxy material Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Jun 20, 2025
10-Q Quarterly report Apr 29, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 29, 2025 Apr 29, 2025
PRE 14A Preliminary proxy statement Apr 16, 2025 Jun 20, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 17, 2025 Mar 17, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
Feb 28, 2025 Feb 24, 2025
10-K Annual report Feb 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 20, 2025 Feb 20, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Nov 25, 2024 Nov 22, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Other events
Sep 11, 2024 Sep 10, 2024
8-K Current report
Material agreement
Aug 21, 2024 Aug 16, 2024
S-8 Employee stock plan registration Aug 1, 2024 —
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 23, 2024 Jul 23, 2024
8-K Current report
Shareholder vote results
Jun 24, 2024 Jun 21, 2024
8-K Current report
Other events
Jun 6, 2024 Jun 4, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 21, 2024
424B5 Prospectus supplement Mar 6, 2024 —
8-K Current report
Material agreement, Other events
Mar 6, 2024 Mar 5, 2024
424B5 Prospectus supplement Mar 4, 2024 —
8-K Current report
Material agreement
Mar 4, 2024 Mar 1, 2024
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 22, 2024 Feb 22, 2024
8-K Current report
Material agreement, Agreement ended, New debt
Jan 18, 2024 Jan 17, 2024
8-K Current report
Other events
Jan 8, 2024 Jan 8, 2024
S-8 Employee stock plan registration Jan 5, 2024 —
S-3ASR Automatic shelf registration Nov 2, 2023 —
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 25, 2023 Sep 25, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
S-3ASR Automatic shelf registration Jul 26, 2023 —
CT ORDER Filing Jul 18, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Jul 17, 2023 Jul 17, 2023
8-K Current report
Shareholder vote results
Jun 22, 2023 Jun 21, 2023
S-8 Employee stock plan registration May 4, 2023 —
8-K Current report
Material agreement, Agreement ended
May 4, 2023 May 3, 2023
S-3ASR Automatic shelf registration May 4, 2023 —
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
8-K Current report
Material agreement, Other events
Mar 9, 2023 Mar 7, 2023
424B5 Prospectus supplement Mar 9, 2023 —
424B5 Prospectus supplement Mar 6, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Mar 6, 2023 Mar 6, 2023
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations, Officer or director change
Feb 23, 2023 Feb 21, 2023
S-8 Employee stock plan registration Feb 6, 2023 —
8-K Current report
Material agreement, New debt
Dec 6, 2022 Nov 30, 2022
8-K Current report
Results of operations, Other events
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Other events
Sep 23, 2022 Sep 23, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations, Other events
Aug 4, 2022 Aug 4, 2022
8-K Current report
Other events
Jul 26, 2022 Jul 26, 2022
8-K Current report
Shareholder vote results
Jun 24, 2022 Jun 22, 2022
8-K Current report
Material agreement, New debt, Other events
May 18, 2022 May 12, 2022
8-K Current report
Material agreement
May 13, 2022 May 12, 2022
8-K Current report
Results of operations
May 10, 2022 May 5, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 22, 2022
S-8 Employee stock plan registration Feb 25, 2022 —
10-K Annual report Feb 25, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Regulation FD disclosure
Dec 27, 2021 Dec 27, 2021
8-K Current report
Shareholder vote results
Dec 16, 2021 Dec 15, 2021
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Nov 18, 2021 Nov 17, 2021
DEF 14A Proxy statement Nov 8, 2021 Dec 15, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
PRE 14A Preliminary proxy statement Oct 29, 2021 Dec 15, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 26, 2021 Oct 23, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 23, 2021 Aug 17, 2021
8-K Current report
Results of operations
Aug 13, 2021 Aug 5, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Shareholder vote results
Jun 22, 2021 Jun 17, 2021
8-K Current report Jun 1, 2021 Jun 1, 2021
8-K Current report
Results of operations
May 14, 2021 May 6, 2021
8-K Current report
Other events
May 11, 2021 May 11, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
DEF 14A Proxy statement Apr 30, 2021 Jun 17, 2021
8-K Current report
Material agreement, New debt
Apr 15, 2021 Apr 13, 2021
8-K Current report
Other events
Mar 31, 2021 Mar 29, 2021
8-K Current report
Results of operations
Feb 26, 2021 Feb 25, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Material agreement, Other events
Feb 17, 2021 Feb 11, 2021
424B7 Filing Feb 16, 2021 —
424B7 Filing Feb 11, 2021 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jan 29, 2021 Jan 25, 2021
8-K Current report
Material agreement, New debt, Other events
Jan 26, 2021 Jan 25, 2021
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Jan 26, 2021 Jan 26, 2021
S-8 Employee stock plan registration Jan 25, 2021 —
S-8 Employee stock plan registration Jan 25, 2021 —
8-K Current report
Shareholder vote results, Other events
Jan 20, 2021 Jan 19, 2021
425 Filing Jan 13, 2021 —
8-K Current report
Other events
Jan 12, 2021 Jan 12, 2021
425 8-k Jan 12, 2021 —
8-K Current report
Officer or director change
Jan 4, 2021 Dec 31, 2020
425 Filing Jan 4, 2021 —
EFFECT Filing Dec 15, 2020 —
DEFM14A Filing Dec 15, 2020 —
424B3 Prospectus Dec 15, 2020 —
CORRESP Letter to the SEC Dec 11, 2020 —
S-4/A Filing Dec 11, 2020 —
UPLOAD Letter from the SEC Nov 13, 2020 —
CORRESP Letter to the SEC Nov 6, 2020 —
S-4 Registration for a merger or exchange Nov 6, 2020 —
8-K Current report
Bylaw or fiscal year change
Nov 6, 2020 Nov 6, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 23, 2020 Oct 21, 2020
8-K Current report
Material agreement
Oct 6, 2020 Oct 5, 2020
425 8-k Oct 6, 2020 —
425 Filing Oct 6, 2020 —
8-K Current report
Other events
Oct 5, 2020 Oct 5, 2020
425 8-k Oct 5, 2020 —
8-K Current report
Regulation FD disclosure
Sep 29, 2020 Sep 29, 2020
10-Q Quarterly report Aug 11, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 11, 2020 Aug 11, 2020
S-3ASR Automatic shelf registration Jul 28, 2020 —
S-3ASR Automatic shelf registration Jul 7, 2020 —
S-8 Employee stock plan registration Jul 7, 2020 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 24, 2020 Jun 23, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 8, 2020 Jun 2, 2020
10-Q Quarterly report May 14, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 13, 2020 May 13, 2020
8-K Current report
Material agreement, New debt
Apr 29, 2020 Apr 27, 2020
DEFA14A Additional proxy material Apr 23, 2020 —
DEF 14A Proxy statement Apr 22, 2020 Jun 2, 2020
8-K Current report
Other events
Mar 24, 2020 Mar 24, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Mar 10, 2020 Mar 4, 2020
8-K Current report
Material agreement, New debt, Other events
Mar 6, 2020 Mar 4, 2020
8-K Current report
Other events
Mar 4, 2020 Mar 4, 2020
S-8 Employee stock plan registration Mar 4, 2020 —
10-K Annual report Mar 3, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 2, 2020 Mar 2, 2020
SEC STAFF LETTER Filing Feb 27, 2020 —
8-K Current report
Officer or director change
Feb 19, 2020 Feb 12, 2020
SEC STAFF LETTER Filing Feb 7, 2020 —
8-K Current report
Material agreement
Jan 7, 2020 Dec 31, 2019
8-K Current report
Results of operations
Dec 26, 2019 Nov 7, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 17, 2019 Dec 12, 2019
S-8 Employee stock plan registration Nov 20, 2019 —
8-K Current report
Material agreement, Other events
Nov 19, 2019 Nov 13, 2019
10-Q Quarterly report Nov 8, 2019 Sep 30, 2019
8-K Current report
Officer or director change
Oct 11, 2019 Oct 7, 2019
8-K Current report
Material agreement, Regulation FD disclosure
Sep 12, 2019 Sep 9, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
Large accelerated filer
SEC CIK
1743881
Former names
BridgeBio Pharma LLC (until May 16, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.